Collegium Pharma (COLL)
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The compa...
- Open
- 23.020
- High
- 23.245
- Low
- 22.640
- Prev. Close
- 22.920
- Volume
- 661.30K
- Turnover
- 15.11M
- Avg Price
- 22.848
- Bid/Ask Ratio
- --
- Amplitude
- 2.64%
- 52wk High
- 50.787
- Volume Ratio
- 2.34
- Turnover Ratio
- 2.18%
Collegium Pharma Analyst Rating
View moreForecast & Rating
Sep 9, 2026Price forecast
$48.86114.76%
Forecast & RatingBuy
7analysts
- Strong buy57.14%
- Buy28.57%
- Hold14.29%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Sep 8 at 12:04 PM
Collegium Pharma management joins Morgan Stanley Global Healthcare Conference fireside chat
- benzinga_article · Sep 3 at 10:09 AM
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In Q3
- Tip Ranks · Aug 19 at 07:27 AM
Barclays Sticks to Their Buy Rating for Collegium Pharmaceutical (COLL)
- Global Report · Aug 18 at 10:12 AM
The Infrastructure Bottleneck: When AI Software Meets Physical Reality
- Unusual Whales · Aug 13 at 11:32 AM
Collegium Announces $50 Million Accelerated Share Repurchase Program
